Wells Fargo’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23
Closed -$10 7394
2025
Q4
$10 Sell
23
-130
-85% -$366 ﹤0.01% 6872
2025
Q3
$700 Hold
153
﹤0.01% 6278
2025
Q2
$599 Hold
153
﹤0.01% 6357
2025
Q1
$619 Hold
153
﹤0.01% 6261
2024
Q4
$1.16K Hold
153
﹤0.01% 6245
2024
Q3
$3.7K Hold
153
﹤0.01% 5969
2024
Q2
$6.39K Sell
153
-11
-7% -$576 ﹤0.01% 5832
2024
Q1
$10.6K Hold
164
﹤0.01% 5745
2023
Q4
$7.39K Buy
164
+2
+1% +$91 ﹤0.01% 5901
2023
Q3
$7.09K Sell
162
-1
-0.6% -$59 ﹤0.01% 5883
2023
Q2
$11.8K Buy
163
+1
+0.6% +$81 ﹤0.01% 5869
2023
Q1
$12.4K Hold
162
﹤0.01% 5790
2022
Q4
$15.6K Hold
162
﹤0.01% 5367
2022
Q3
$18K Hold
162
﹤0.01% 5453
2022
Q2
$20K Buy
162
+1
+0.6% +$88 ﹤0.01% 5453
2022
Q1
$12K Hold
161
﹤0.01% 6210
2021
Q4
$12K Hold
161
﹤0.01% 6488
2021
Q3
$8K Hold
161
﹤0.01% 6276
2021
Q2
$9K Hold
161
﹤0.01% 6180
2021
Q1
$12K Buy
161
+156
+3,120% +$15K ﹤0.01% 6288
2020
Q4
$0 Hold
5
﹤0.01% 6885
2020
Q3
$0 Sell
5
-1
-17% -$24 ﹤0.01% 6755
2020
Q2
$0 Hold
6
﹤0.01% 6689
2020
Q1
$0 Buy
+6
New +$112 ﹤0.01% 6655
2019
Q2
Sell
-10
Closed 6552
2019
Q1
$0 Sell
10
-490
-98% -$15.1K ﹤0.01% 6361
2018
Q4
$16K Sell
500
-500
-50% -$15.2K ﹤0.01% 5827
2018
Q3
$30K Hold
1,000
﹤0.01% 5737
2018
Q2
$33K Buy
+1,000
New +$33.1K ﹤0.01% 5706

Other funds holding PRPH

Wells Fargo's PRPH Position: Q1 2026 in Review

Wells Fargo sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 23 shares — an estimated $10 sold.

Wells Fargo first reported a position in PRPH in Q2 2018 and held it in 28 quarters. The position peaked at $33K in Q2 2018. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

  • Wells Fargo reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 23 ProPhase Labs shares in Q1 2026, an estimated $10.
  • Wells Fargo first reported a position in ProPhase Labs in Q2 2018 and held it in 28 quarters.
  • Wells Fargo's ProPhase Labs position peaked at $33K in Q2 2018.
  • 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.